First patient enrolled in phase III study of troriluzole in generalized anxiety disorder Feb. 21, 2019
Catabasis reports growth data from phase II trial of edasalonexent for Duchenne muscular dystrophy Feb. 20, 2019
Inosine supplementation and modulation of adenosine deaminase as a potential therapy against ALS Feb. 20, 2019
RSS